NSPH


Stock Update (NASDAQ:NSPH): Nanosphere, Inc. Presented Eighteen New Verigene Clinical and Economic Studies at CVS, ECCMID and MAD-ID 2015

Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, announced that 18 studies performed by various U.

Wednesday’s Pre-Market Insights: Petroleo Brasileiro Petrobras SA, Seadrill Ltd, Nanosphere, Inc., Workday Inc

Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) shares increased 4.11% to $8.

Company Update (NASDAQ:NSPH): Nanosphere, Inc. Announces Closing of New and Expanded Debt Facility and $4.4 Million at the Market Registered Direct Offering

Nanosphere, Inc. (NASDAQ:NSPH) , a company enhancing medicine through targeted molecular diagnostics, announced the closing of its previously announced registered direct offering of …

Stock Update (NASDAQ:NSPH): Nanosphere, Inc. Announces Record Q1 2015 Results, New and Expanded Debt Facility, $4.4 Million at the Market Registered Direct Offering

Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, today reported financial and operating results for the first quarter ended March 31, …

Company Update (NASDAQ:NSPH): Nanosphere, Inc. Announces Reverse Split of Common Stock

Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, announced that a 20-to-1 reverse split of its common stock will be effective …

Stock Update (NASDAQ:NSPH): Scripps Study Illustrates Clinical and Economic Impact of Verigene BC-GP Rapid Blood Culture Test With Antibiotic Stewardship Intervention

Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, and Scripps Health, a private, nonprofit, integrated health system in San Diego, California, today announced …

Roth Capital Slashes Nanosphere Price Target In Half Following 4Q14 Results

In a research report sent to investors, Roth Capital analyst Chris Lewis reiterated a Buy rating on Nanosphere (NASDAQ:NSPH), but reduced the price …

Company Update (NASDAQ:NSPH):Nanosphere to Release Preliminary Fourth Quarter & Fiscal Year 2014 Results and Host Investor Conference Call

Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will report preliminary results for the fourth quarter …

Canaccord Keeps Positive Outlook On Nanosphere As It Explores Strategic Alternatives

In a research note published Monday, Canaccord analyst Mark Massaro reiterated a Buy rating on Nanosphere (NASDAQ:NSPH) with a $3 price target, in …

Nanosphere Could Be An Attractive Takeout Candidate, Says Roth Capital; Keeps $1.50 PT

In a research report published today, Roth Capital analyst Chris Lewis reiterated a Buy rating on Nanosphere (NASDAQ:NSPH) with a $1.50 price target, as NSPH …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts